High levels of amyloid-beta protein from S182 (Glu246) familial Alzheimer's cells

Neuroreport. 1995 Dec 29;7(1):217-20.

Abstract

Most early-onset familial Alzheimer disease is associated with missense mutations in S182, a membrane protein on chromosome 14. We investigated amyloid-beta protein (A beta) precursor (A beta PP) metabolism in skin fibroblasts from S182 (Glu246)-affected individuals and unaffected family members. Steady-state A beta PP levels were similar among all lines as was the degree of increase in soluble A beta PP released upon stimulation of cells with either phorbol ester or serum. Among all lines studied, A beta levels were consistently detectable only in the medium of a single line of S182 (Glu246) cells, consistent with the conclusion that some S182 mutant lines may accumulate A beta in their conditioned media. Studies of cells from additional individuals and under other conditions will be required to establish this association of elevated A beta levels with S182 mutations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Age of Onset
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / pathology
  • Amyloid beta-Protein Precursor / metabolism*
  • Blood Physiological Phenomena
  • Case-Control Studies
  • Cells, Cultured
  • Culture Media, Conditioned
  • Fibroblasts / metabolism
  • Humans
  • Membrane Proteins / genetics*
  • Nerve Tissue Proteins / genetics*
  • Phorbol 12,13-Dibutyrate / pharmacology
  • Point Mutation*
  • Presenilin-1
  • Skin / cytology
  • Skin / metabolism

Substances

  • Amyloid beta-Protein Precursor
  • Culture Media, Conditioned
  • Membrane Proteins
  • Nerve Tissue Proteins
  • PSEN1 protein, human
  • Presenilin-1
  • Phorbol 12,13-Dibutyrate